Metropolis Healthcare Limited has informed the Exchange about Grant of Stock Benefits
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Metropolis Healthcare's Nomination and Remuneration Committee approved stock benefits for eligible employees on November 4, 2025. The grant covers 18,232 units under the RSU Plan 2020 and 10,107 units under the RSU Plan 2025, both at face value of INR 2 per unit. Additionally, 228,840 options were granted under the new ESOP 2025 at an exercise price of INR 1,648.24 per option. All grants have a minimum vesting period of 1 year, extendable up to 4 years, with a maximum exercise window of 5 years from vesting. In total, up to 257,179 shares could be issued under these grants.
This is a routine employee stock benefit grant with limited near-term dilution (about 257,179 shares). The RSU grants at face value are more favorable to employees than the ESOP at market-linked pricing, but overall the impact on existing shareholders is modest and aligned with standard retention and incentive practices.